[{"address1": "3001 Daimler Street", "city": "Santa Ana", "state": "CA", "zip": "92705", "country": "United States", "phone": "949-396-6830", "website": "https://nkgenbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.", "fullTimeEmployees": 63, "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul Y.  Song M.D.", "age": 57, "title": "CEO & Chairman", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 650000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Yong Man  Kim Ph.D.", "age": 58, "title": "Chief Scientific Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 60000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James A. Graf", "age": 58, "title": "Interim Chief Financial Officer", "yearBorn": 1965, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoonmi  Kang", "title": "SVP of Technical Ops & Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Irene  Chang", "title": "SVP, HR & Corporate Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Denise A. Chua CLS, MBA, MT (ASCP)", "title": "SVP of Corporate Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Park C.F.A.", "title": "EVP of Financial Planning & Analysis and Corporate Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4498, "open": 0.443, "dayLow": 0.375, "dayHigh": 0.45, "regularMarketPreviousClose": 0.4498, "regularMarketOpen": 0.443, "regularMarketDayLow": 0.375, "regularMarketDayHigh": 0.45, "beta": 0.524, "volume": 291668, "regularMarketVolume": 291668, "averageVolume": 1403974, "averageVolume10days": 1160780, "averageDailyVolume10Day": 1160780, "bid": 0.315, "ask": 0.505, "bidSize": 200, "askSize": 200, "marketCap": 15502876, "fiftyTwoWeekLow": 0.203, "fiftyTwoWeekHigh": 4.06, "fiftyDayAverage": 0.34656, "twoHundredDayAverage": 1.018085, "currency": "USD", "enterpriseValue": 43515864, "floatShares": 16304884, "sharesOutstanding": 35362400, "sharesShort": 691794, "sharesShortPriorMonth": 432022, "sharesShortPreviousMonthDate": 1728950400, "dateShortInterest": 1731628800, "sharesPercentSharesOut": 0.0196, "heldPercentInsiders": 0.42323002, "heldPercentInstitutions": 0.12191, "shortRatio": 0.28, "shortPercentOfFloat": 0.0688, "impliedSharesOutstanding": 35362400, "bookValue": -2.705, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -88253000, "trailingEps": -3.42, "enterpriseToEbitda": -1.44, "52WeekChange": -0.8668639, "SandP52WeekChange": 0.31426477, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "NKGN", "underlyingSymbol": "NKGN", "shortName": "NKGen Biotech, Inc.", "longName": "NKGen Biotech, Inc.", "firstTradeDateEpochUtc": 1696253400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "fcdfc701-b224-3dd9-a78d-de29fa809024", "messageBoardId": "finmb_595547196", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.4384, "recommendationKey": "none", "totalCash": 79000, "totalCashPerShare": 0.002, "ebitda": -30226000, "totalDebt": 28092000, "quickRatio": 0.002, "currentRatio": 0.024, "returnOnAssets": -1.06845, "freeCashflow": 12745500, "operatingCashflow": -21537000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]